Browsing by Author Gazi, I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 25  next >
TitleAuthor(s)Issue date
The apolipoprotein B/apolipoprotein A1 ratio in metabolic syndromeGazi, I.; Tzovaras, V.; Liberopoulos, E.; Tsouli, S.; Spyrou, A.; Tselepis, A.; Elisaf, M.24-Nov-2015
Beneficial effects of omega-3 fatty acids: the current evidenceGazi, I.; Liberopoulos, E. N.; Saougos, V. G.; Elisaf, M. S.24-Nov-2015
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteriaGazi, I.; Tsimihodimos, V.; Filippatos, T.; Bairaktari, E.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemiaKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Filippatos, T.; Saougos, V.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M.24-Nov-2015
Effect of ezetimibe on lipoprotein subfractions in patients with primary dyslipidemiasKalogirou, M.; Tsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Effect of rosuvastatin on low density lipoprotein (LDL) concentration and relative distribution in patients with primary dyslipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Milionis, H.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Effect of rosuvastatin on low density lipoprotein (LDL) profile in patients with primary dyslipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Saougos, V. G.; Milionis, H. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Effects of orlistat and fenofibrate combination on LDL phenotype in overweight and obese patients with metabolic syndrome. The fenorli studyFilippatos, T. D.; Kiortsis, D. N.; Gazi, I.; Liberopoulos, E. N.; Georgoula, M.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Effects of rosuvastatin on serum homocysteine, vitamin B12 and folic acid levels in patients with primary hyperlipidemiaChasiotis, G.; Milionis, H.; Gazi, I.; Filippatos, T.; Bairaktari, E.; Elisaf, M. S.; Seferiadis, K.24-Nov-2015
Evaluation of the ability of simple lipid measures to predict the presence of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kalogirou, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
EVIDENCE OF INCREASED SDLDL PARTICLES DURING ACUTE INFECTION WITH EPSTEIN-BARR VIRUSApostolou, F.; Gazi, I.; Saougos, V.; Tselepis, A.; Elisaf, M. S.; Liberopoulos, E.24-Nov-2015
The hypertriglyceridaemic waist phenotype as a marker of the atherogenic lipoprotein profile in metabolic syndromeGazi, I.; Tsimihodimos, V.; Liamis, G.; Kostapanos, M.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndromeTsimihodimos, V.; Gazi, I.; Kalaitzidis, R.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015
LDL cholesterol estimation in patients with the metabolic syndromeGazi, I.; Tsimihodimos, V.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
LDL subfractions in patients with metabolic syndromeGazi, I.; Filippatos, T.; Bairaktari, E.; Kostara, C.; Tselepis, A.; Elisaf, M. S.24-Nov-2015
Lipid Profile and Serum Levels of Markers of Inflammation in Patients with Acute BrucellosisApostolou, F.; Gazi, I.; Tselepis, A.; Elisaf, M.; Liberopoulos, E.24-Nov-2015
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndromeRizos, E.; Tambaki, A. P.; Gazi, I.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Lipoprotein-associated phospholipase A(2) activity is a marker of small, dense LDL particles in human plasmaGazi, I.; Lourida, E. S.; Filippatos, T.; Tsimihodimos, V.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015